Amgen Inc.
METHODS OF TREATING HEART FAILURE BY ADMINISTERING OMECAMTIV MECARBIL

Last updated:

Abstract:

Provided herein are methods of treating heart failure in patients exhibiting one or more additional features, comprising administering to the patient a therapeutically effective amount of omecamtiv mecarbil, or a hydrate, salt, or salt of a hydrate thereof.

Status:
Application
Type:

Utility

Filling date:

11 Nov 2021

Issue date:

16 Jun 2022